About
Synvect develops CRISPR-based biological solutions that sterilize mosquito eggs to suppress and eliminate disease-carrying mosquito populations, aiming to reduce mosquito-borne diseases effectively and sustainably.
Explore Synvect's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.